Systematic review with meta-analysis: The proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 4, 2014, Pages 349-358

  Chao, D T ^a   Lim, J K ^b   Ayoub, W S ^c   Nguyen, L H ^d   Nguyen, M H ^e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIGEN; VIRUS DNA;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; DISEASE COURSE; DNA DETERMINATION; ETHNIC DIFFERENCE; HEPATITIS B; HUMAN; LIVER FIBROSIS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADULT; ALANINE TRANSAMINASE; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84892877942     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12590     Document Type: Article

References (51)

1. Lavanchy D, Hepatitis B,. virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. Lok AS, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45: 507-39.
3. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
4. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC,. Public Policy Committee of the American Association for the Study of Liver D. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008; 47: 1363-70.
5. Prati D, Taioli E, Zanella A, et al,. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
6. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ,. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2007; 46: 1057-70.
7. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I,. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
8. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
9. Andreani T, Serfaty L, Mohand D, et al,. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. Clin Gastroenterol Hepatol 2007; 5: 636-41.
10. Chen EQ, Huang FJ, He LL, et al,. Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci 2010; 55: 432-7.
11. Croagh CM, Bell SJ, Slavin J, et al,. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Liver Int 2010; 30: 1115-22.
12. Dixit VK, Panda K, Babu AV, et al,. Asymptomatic chronic hepatitis B virus infection in northern India. Indian J Gastroenterol 2007; 26: 159-61.
13. El-Zayadi AR, Badran HM, Saied A, Shawky S, Attia Mel D, Zalata K,. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy. Am J Gastroenterol 2009; 104: 906-11.
14. Hu KQ, Schiff ER, Kowdley KV, et al,. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels. J Clin Gastroenterol 2010; 44: 510-6.
15. Hui CK, Leung N, Yuen ST, et al,. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 2007; 46: 395-401.
16. Ikeda K, Arase Y, Saitoh S, et al,. Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase. Am J Med 2006; 119: 977-85.
17. Lesmana CR, Gani RA, Hasan I, et al,. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia. J Dig Dis 2011; 12: 476-80.
18. Lu CT, Gao GS,. Association of liver histopathology and clinical features among patients with chronic hepatitis B virus infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2011; 25: 214-6.
19. Mbaye PS, Sarr A, Sire JM, et al,. Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load. PLoS ONE 2011; 6: e22291.
20. Xian JC, Xu HT, He YL, et al,. Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN. Zhonghua Gan Zang Bing Za Zhi 2011; 19: 431-5.
21. Chan HL, Wong GL, Choi PC, et al,. Clinical factors predicting advanced liver fibrosis in hepatitis B E antigen positive chronic hepatitis B. J Hepatol 2009; 50: S134.
22. Gobel T, Erhardt A, Herwig M, et al,. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe. J Med Virol 2011; 83: 968-73.
23. Gui HL, Xie Q, Wang H, et al,. Histological changes in the livers of chronic hepatitis B patients with persistently normal serum alanine transaminase levels. Zhonghua Gan Zang Bing Za Zhi 2007; 15: 881-5.
24. Li J, Zhao GM, Li Y, Liu JJ, Zhu LM, Liang SR,. Hepatic pathology and clinical characteristics of patients with chronic hepatitis B virus in immune tolerant phase. Hep Intl 2009; 3: 127.
25. Li YB, Dong J, Liu YR, Jiang JJ,. Analysis of liver histopathology and liver function in liver cirrhosis of patients infected hepatitis b with persistently normal ALT levels. Hep Intl 2011; 5: 83.
26. Rahman MM, Kafi MA, Kibria MG, et al,. Histological changes of chronic hepatitis B patients in Bangladesh with normal or minimally elevated ALT. J Gastroenterol Hepatol 2010; 25: A110-1.
27. Mansour-Ghanaei F, Rafiei R, Joukar F, et al,. Relationship between serum HBV DNA level and liver histology in HBV carriers with normal ALT in Guilan province, Iran. Med Sci Monit 2010; 16: BR97-101.
28. Lin CL, Liao LY, Liu CJ, et al,. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 2007; 45: 1193-8.
29. Fan HM, Yang Z, Zhang CL, Li WL,. Liver histopathological features of chronic HBV carriers and inactive HBsAg carriers. Zhonghua Gan Zang Bing Za Zhi 2007; 15: 334-7.
30. Mamun-Al-Mahtab M, Rahman S, Khan M, Karim F, Kamal M,. Liver histopathological features of HBeAg-negative chronic hepatitis B in young Bangladeshis. Hepat Mon 2009; 9: 29-33.
31. Seto WK, Lai CL, Fung J, Yuen J, Wong DKH, Yuen MF,. Elevation of ALT fails to predict significant histologic abnormalities in chronic hepatitis B patients. Hep Intl 2011; 5: 164.
32. Shi M, Zhang Y, Zhang J, Liu W, Xing L,. Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels. Braz J Infect Dis 2012; 16: 52-6.
33. Yen-Cheng C, Tseng KC, Chen CY, et al,. Lower ALT level could not differentiate liver pathology in CHB patients with high viral load and persistent normal ALT. Hep Intl 2012; 6: 85-6.
34. Yu J, He D, An Y, et al,. Study of liver biopsy in chronic HBV carriers with persistently normal aminotransferase levels. Hep Intl 2012; 6: 86-7.
35. Wang CC, Lim LY, Deubner H, et al,. Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT. J Clin Gastroenterol 2008; 42: 820-6.
36. Papatheodoridis GV, Manesis EK, Manolakopoulos S, et al,. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology 2008; 48: 1451-9.
37. Chotiyaputta W, Degertekin B, McKenna BJ, Samala N, Fontana RJ, Lok ASF,. Characteristics of chronic hepatitis B patients who underwent liver biopsies. J Viral Hepatitis 2011; 18: 792-803.
38. Cheong JY, Kim DJ, Hwang SG, et al,. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int 2011; 31: 1352-8.
39. Yang L, Xu K, Zhao Y, et al,. Clinical significance of liver biopsy in chronic hepatitis B patients with persistently normal transaminase. Chin J Dig Dis 2002; 3: 150-3.
40. Alallam A, Adeyi O, Fung S,. Significant liver fibrosis can be found among chronic hepatitis B patients with minimally elevated ALT. Hepatology 2010; 52 (Suppl. S1): 998A.
41. Nguyen MH, Garcia RT, Trinh HN, et al,. Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels. Am J Gastroenterol 2009; 104: 2206-13.
42. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH,. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007; 47: 760-7.
43. Park JY, Park YN, Kim DY, et al,. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. J Viral Hepat 2008; 15: 615-21.
44. Charatcharoenwitthaya P, Phisalprapa P, Rungkaew P, et al,. Liver biochemical course, serum HBV DNA and liver stiffness measurement for therapeutic decisions in HBeAg-negative chronic hepatitis B infection. Gastroenterology 2011; 140: S-896.
45. Kumar M, Sarin SK, Hissar S, et al,. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-84.
46. Alam S, Ahmad N, Mustafa G, Shrestha A, Alam AK, Khan M,. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B. Liver Int 2011; 31: 824-30.
47. Molina-Perez E, Castroagudin JF, Aguilera-Guirao A, et al,. Viral and host factors related with histopathologic activity in patients with chronic hepatitis B and moderate or intermittently elevated alanine aminotransferase levels. Rev Esp Enferm Dig 2010; 102: 519-25.
48. Martinot-Peignoux M, Boyer N, Colombat M, et al,. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002; 36: 543-6.
49. Montazeri G, Rahban M, Mohamadnejad M, et al,. Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase. Arch Iran Med 2010; 13: 193-202.
50. Piton A, Poynard T, Imbert-Bismut F, et al,. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998; 27: 1213-9.
51. Kariv R, Leshno M, Beth-Or A, et al,. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 2006; 26: 445-50.